GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R208. A total of 14 filers reported holding GENETIC TECHNOLOGIES LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $15,000 | +50.0% | 25,536 | +123.5% | 0.00% | – |
| Q1 2019 | $10,000 | +233.3% | 11,426 | +181.9% | 0.00% | – |
| Q4 2018 | $3,000 | +200.0% | 4,053 | +211.8% | 0.00% | – |
| Q3 2018 | $1,000 | -80.0% | 1,300 | -75.3% | 0.00% | – |
| Q2 2018 | $5,000 | +66.7% | 5,267 | +55.0% | 0.00% | – |
| Q1 2018 | $3,000 | +50.0% | 3,398 | +69.9% | 0.00% | – |
| Q4 2017 | $2,000 | -80.0% | 2,000 | -82.8% | 0.00% | – |
| Q3 2017 | $10,000 | 0.0% | 11,651 | +3.3% | 0.00% | – |
| Q2 2017 | $10,000 | 0.0% | 11,283 | +38.2% | 0.00% | – |
| Q1 2017 | $10,000 | +900.0% | 8,165 | +716.5% | 0.00% | – |
| Q4 2016 | $1,000 | -80.0% | 1,000 | -61.9% | 0.00% | – |
| Q3 2016 | $5,000 | -76.2% | 2,628 | -74.2% | 0.00% | – |
| Q2 2016 | $21,000 | +110.0% | 10,190 | +162.6% | 0.00% | – |
| Q4 2015 | $10,000 | 0.0% | 3,881 | +113.6% | 0.00% | – |
| Q1 2015 | $10,000 | – | 1,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 28,437 | $30,000 | 0.01% |
| Virtu Financial LLC | 37,505 | $39,000 | 0.00% |
| Renaissance Technologies | 982,980 | $1,022,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 2,750 | $3,000 | 0.00% |
| JANE STREET GROUP, LLC | 13,527 | $14,000 | 0.00% |
| UBS Group AG | 3,398 | $3,000 | 0.00% |
| CITIGROUP INC | 300 | $0 | 0.00% |
| MORGAN STANLEY | 1,520 | $2,000 | 0.00% |
| Financial Architects, Inc | 350 | $0 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 12,000 | $12,000 | 0.00% |